Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V Mutation
Clinical trial NCT00312039 · COMPLETED
Trial details
- NCT number
- NCT00312039
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-31
- Primary completion
- 2007-10-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.